Golden Dragon China Invesco ETF (PGJ)
$51.55 0.10 (0.20%)
16:00 EDT PGJ Stock Quote Delayed 30 Minutes
Previous Close $51.55
Market Cap 298.99M
PE Ratio -
Volume (Avg. Vol.) 26,300
Day's Range 51.43 - 52.22
52-Week Range 30.00 - 54.67
Dividend & Yield 0.71 (1.38%)
PGJ Stock Predictions, Articles, and Golden Dragon China Invesco ETF News
- From InvestorPlace
- From the Web
With the recent escalation in the trade war spat between the U.S. and China and the G20 summit imminent, Chinese ETFs are struggling.
Chinese ETFs have potential to rebound, but are fraught with risk as well. Here are seven ETFs investors need to be cautious about.
China's rebounding domestic economy has created incredible opportunities investors. Based on the holdings of GAM China Evolution Fund, here are some Chinese stocks from the consumer, financial and healthcare sectors, including several less-familiar names.
By Jeff Reeves
The 10 Best ETFs of 2017 all put up gains of more than 50%. More importantly, these are the best ETFs with strong momentum as we enter 2018.
Many of the best Chinese ETFs, though still undiscovered by many investors, focus on the country's new economy. Here are some of the best to consider right now.
Despite the current hiccups, China ETFs belong in your portfolio for the long-term. Here are three of the best funds to buy.
The recent Hong Kong protests have caused a sell-off in Chinese ETFs such as FXI, GXC and MCHI. That means now is the time to buy Chinese ETFs while they're on sale.
From Analyst Ratings
In a report released today, Andrew D’silva from B.Riley FBR maintained a Buy rating on Cumberland Pharmaceuticals (CPIX – Research Report), with a price target of $9.75. The company’s shares closed last Wednesday at $3.75, close to its 52-week low of $3.32. According to TipRanks.com, D’silva is a 4-star analyst with an average return of
From Simply Wall St
David Iben put it well when he said, ‘Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.’ It’s only natural<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cpix/cumberland-pharmaceuticals/news/is-cumberland-pharmaceuticals-nasdaqcpix-using-debt-sensibly/">Read More...</a></div>